BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li MD, Atkins H, Bubela T. The global landscape of stem cell clinical trials. Regen Med. 2014;9:27-39. [PMID: 24236476 DOI: 10.2217/rme.13.80] [Cited by in Crossref: 119] [Cited by in F6Publishing: 121] [Article Influence: 13.2] [Reference Citation Analysis]
Number Citing Articles
1 Choudhury MC, Chakraborty I, Saberwal G. Discrepancies between FDA documents and ClinicalTrials.gov for Orphan Drug-related clinical trial data. PLOS Glob Public Health 2022;2:e0000261. [DOI: 10.1371/journal.pgph.0000261] [Reference Citation Analysis]
2 Gao J, Gao C. Development and regulation of stem cell-based therapies in China. Cell Prolif 2022;:e13217. [PMID: 35419811 DOI: 10.1111/cpr.13217] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Afrough A, Heslop HE, Hill LC. Commercialization of Investigational Cell Therapy Products. Cell Therapy 2022. [DOI: 10.1007/978-3-030-75537-9_9] [Reference Citation Analysis]
4 Kim JY, Nam Y, Rim YA, Ju JH. Review of the Current Trends in Clinical Trials Involving Induced Pluripotent Stem Cells. Stem Cell Rev Rep 2021. [PMID: 34532844 DOI: 10.1007/s12015-021-10262-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
5 Kraus L, Bryan C, Wagner M, Kino T, Gunchenko M, Jalal W, Khan M, Mohsin S. Bmi1 Augments Proliferation and Survival of Cortical Bone-Derived Stem Cells after Injury through Novel Epigenetic Signaling via Histone 3 Regulation. Int J Mol Sci 2021;22:7813. [PMID: 34360579 DOI: 10.3390/ijms22157813] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Acero L. Framing regenerative medicine: culturally specific stories of an emerging technoscience. BioSocieties. [DOI: 10.1057/s41292-021-00236-6] [Reference Citation Analysis]
7 Corrêa RR, Juncosa EM, Masereeuw R, Lindoso RS. Extracellular Vesicles as a Therapeutic Tool for Kidney Disease: Current Advances and Perspectives. Int J Mol Sci 2021;22:5787. [PMID: 34071399 DOI: 10.3390/ijms22115787] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
8 Barrera JA, Trotsyuk AA, Maan ZN, Bonham CA, Larson MR, Mittermiller PA, Henn D, Chen K, Mays CJ, Mittal S, Mermin-Bunnell AM, Sivaraj D, Jing S, Rodrigues M, Kwon SH, Noishiki C, Padmanabhan J, Jiang Y, Niu S, Inayathullah M, Rajadas J, Januszyk M, Gurtner GC. Adipose-Derived Stromal Cells Seeded in Pullulan-Collagen Hydrogels Improve Healing in Murine Burns. Tissue Eng Part A 2021;27:844-56. [PMID: 33789446 DOI: 10.1089/ten.TEA.2020.0320] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
9 Venugopal N, Saberwal G. A comparative analysis of important public clinical trial registries, and a proposal for an interim ideal one. PLoS One 2021;16:e0251191. [PMID: 33974649 DOI: 10.1371/journal.pone.0251191] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
10 Kusena JWT, Shariatzadeh M, Thomas RJ, Wilson SL. Understanding cell culture dynamics: a tool for defining protocol parameters for improved processes and efficient manufacturing using human embryonic stem cells. Bioengineered 2021;12:979-96. [PMID: 33757391 DOI: 10.1080/21655979.2021.1902696] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Wyles SP, Monie DD, Paradise CR, Meyer FB, Hayden RE, Terzic A. Emerging workforce readiness in regenerative healthcare. Regen Med 2021;16:197-206. [PMID: 33622054 DOI: 10.2217/rme-2020-0137] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
12 Boutin SR, Sherley JL. Advancing Quantitative Stem Cell Dosing for Veterinary Stem Cell Medicine. Stem Cells in Veterinary Science 2021. [DOI: 10.1007/978-981-16-3464-2_12] [Reference Citation Analysis]
13 Rajendran RL, Jogalekar MP, Gangadaran P, Ahn BC. Noninvasive in vivo cell tracking using molecular imaging: A useful tool for developing mesenchymal stem cell-based cancer treatment. World J Stem Cells 2020; 12(12): 1492-1510 [PMID: 33505597 DOI: 10.4252/wjsc.v12.i12.1492] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
14 Martínez-Santamaría L, Cárcamo C, García-Pardo L, García-Arranz M, Melen G, Guerrero-Aspizua S, Llanos L, Río MD, García-Olmo D, Escámez MJ. Combined adipose mesenchymal stromal cell advanced therapy resolved a recalcitrant leg ulcer in an 85-year-old patient. Regen Med 2020;15:2053-65. [PMID: 33245008 DOI: 10.2217/rme-2020-0139] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Kobold S, Guhr A, Mah N, Bultjer N, Seltmann S, Seiler Wulczyn AEM, Stacey G, Jie H, Liu W, Löser P, Kurtz A. A Manually Curated Database on Clinical Studies Involving Cell Products Derived from Human Pluripotent Stem Cells. Stem Cell Reports 2020;15:546-55. [PMID: 32679065 DOI: 10.1016/j.stemcr.2020.06.014] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]
16 Kumari S, Mohan A, Saberwal G. Hidden duplicates: 10s or 100s of Indian trials, registered with ClinicalTrials.gov, have not been registered in India, as required by law. PLoS One 2020;15:e0234925. [PMID: 32559240 DOI: 10.1371/journal.pone.0234925] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
17 Dong Y, Cui M, Qu J, Wang X, Kwon SH, Barrera J, Elvassore N, Gurtner GC. Conformable hyaluronic acid hydrogel delivers adipose-derived stem cells and promotes regeneration of burn injury. Acta Biomater 2020;108:56-66. [PMID: 32251786 DOI: 10.1016/j.actbio.2020.03.040] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 20.0] [Reference Citation Analysis]
18 Gorbunova EA, Krivosheina OI, Mustafina LR. Formation of eyeball orbital stump using titanium nickelide tissue-engineered construct and autologous blood mononuclear leukocytes. RJTAO 2020;22:157-164. [DOI: 10.15825/1995-1191-2020-1-157-164] [Reference Citation Analysis]
19 Jacques E, Suuronen EJ. The Progression of Regenerative Medicine and its Impact on Therapy Translation. Clin Transl Sci 2020;13:440-50. [PMID: 31981408 DOI: 10.1111/cts.12736] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
20 Rotolo A, Chabannon C, Gramignoli R. Identification of hurdles in the development of cell-based therapies. Cytotherapy 2020;22:53-6. [PMID: 32081172 DOI: 10.1016/j.jcyt.2019.12.009] [Reference Citation Analysis]
21 Couto PS, Bersenev A, Rafiq QA. Process development and manufacturing approaches for mesenchymal stem cell therapies. Engineering Strategies for Regenerative Medicine 2020. [DOI: 10.1016/b978-0-12-816221-7.00002-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
22 Navaei T, Hasani S, Derakhshani A. Nanoengineering of stem cells for musculoskeletal regeneration. Nanoengineering in Musculoskeletal Regeneration 2020. [DOI: 10.1016/b978-0-12-820262-3.00006-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Lam C, Meinert E, Yang A, Brindley DA, Cui Z. Decisions in the Development Lifecycle of Cell and Gene Therapies. Second Generation Cell and Gene-based Therapies 2020. [DOI: 10.1016/b978-0-12-812034-7.00022-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Ehanire TE, Katz AJ. Challenges and Status of Adipose Cell Therapies: Translation and Commercialization. Cell Engineering and Regeneration 2020. [DOI: 10.1007/978-3-319-08831-0_56] [Reference Citation Analysis]
25 Kabat M, Bobkov I, Kumar S, Grumet M. Trends in mesenchymal stem cell clinical trials 2004-2018: Is efficacy optimal in a narrow dose range? Stem Cells Transl Med. 2020;9:17-27. [PMID: 31804767 DOI: 10.1002/sctm.19-0202] [Cited by in Crossref: 193] [Cited by in F6Publishing: 203] [Article Influence: 64.3] [Reference Citation Analysis]
26 Zarzeczny A. The Future of Stem Cell Research and its Clinical Translation in Canada: Exploring Questions of Governance and Policy Options. Adv Exp Med Biol 2020;1247:1-16. [PMID: 31749135 DOI: 10.1007/5584_2019_450] [Reference Citation Analysis]
27 Kishi N. How does policy focus influence scientific research? Science and Public Policy 2020;47:114-24. [DOI: 10.1093/scipol/scz051] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
28 Park S, Park HH, Sun K, Gwon Y, Seong M, Kim S, Park TE, Hyun H, Choung YH, Kim J, Jeong HE. Hydrogel Nanospike Patch as a Flexible Anti-Pathogenic Scaffold for Regulating Stem Cell Behavior. ACS Nano 2019;13:11181-93. [PMID: 31518110 DOI: 10.1021/acsnano.9b04109] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 12.7] [Reference Citation Analysis]
29 Patras L, Banciu M. Intercellular Crosstalk Via Extracellular Vesicles in Tumor Milieu as Emerging Therapies for Cancer Progression. CPD 2019;25:1980-2006. [DOI: 10.2174/1381612825666190701143845] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
30 Higham R. Imagining the future of cell therapies: clinical trials, innovation and the intersection of clinical-academic and commercial visions. New Genetics and Society 2019;38:363-86. [DOI: 10.1080/14636778.2019.1642742] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
31 MacPherson A, Kimmelman J. Ethical development of stem-cell-based interventions. Nat Med 2019;25:1037-44. [PMID: 31270501 DOI: 10.1038/s41591-019-0511-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
32 Al-Jaibaji O, Swioklo S, Connon CJ. Mesenchymal stromal cells for ocular surface repair. Expert Opin Biol Ther 2019;19:643-53. [PMID: 30979344 DOI: 10.1080/14712598.2019.1607836] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
33 Santamaria X, Mas A, Cervelló I, Taylor H, Simon C. Uterine stem cells: from basic research to advanced cell therapies. Hum Reprod Update 2018;24:673-93. [PMID: 30239705 DOI: 10.1093/humupd/dmy028] [Cited by in Crossref: 67] [Cited by in F6Publishing: 67] [Article Influence: 22.3] [Reference Citation Analysis]
34 Couto PS, Shatirishvili G, Bersenev A, Verter F. First decade of clinical trials and published studies with mesenchymal stromal cells from umbilical cord tissue. Regenerative Medicine 2019;14:309-19. [DOI: 10.2217/rme-2018-0171] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
35 Farina M, Alexander JF, Thekkedath U, Ferrari M, Grattoni A. Cell encapsulation: Overcoming barriers in cell transplantation in diabetes and beyond. Adv Drug Deliv Rev 2019;139:92-115. [PMID: 29719210 DOI: 10.1016/j.addr.2018.04.018] [Cited by in Crossref: 84] [Cited by in F6Publishing: 80] [Article Influence: 28.0] [Reference Citation Analysis]
36 Chen S, Ren J, Chen R. Cryopreservation and Desiccation Preservation of Cells. Comprehensive Biotechnology 2019. [DOI: 10.1016/b978-0-444-64046-8.00451-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Fasha I, Liem IK, Antarianto RD, Sianipar IR, Yunaini L. Comparison study of human mononuclear cells presence in rat blood using flow cytometry and polymerase chain reaction. AIP Conference Proceedings 2019. [DOI: 10.1063/1.5096714] [Reference Citation Analysis]
38 de Windt T, Niemansburg S, Vonk L, van Delden J, Roes K, Dhert W, Saris D, Bredenoord A. Ethics in musculoskeletal regenerative medicine; guidance in choosing the appropriate comparator in clinical trials. Osteoarthritis and Cartilage 2019;27:34-40. [DOI: 10.1016/j.joca.2018.08.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
39 Lazurko C, Jacques E, Ahumada M, Alarcon EI. Nanomaterials for Its Use in Biomedicine: An Overview. Nanoengineering Materials for Biomedical Uses 2019. [DOI: 10.1007/978-3-030-31261-9_1] [Reference Citation Analysis]
40 Lam C, Meinert E, Alturkistani A, Carter AR, Karp J, Yang A, Brindley D, Cui Z. Decision Support Tools for Regenerative Medicine: Systematic Review. J Med Internet Res 2018;20:e12448. [PMID: 30567696 DOI: 10.2196/12448] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
41 International Collaboration and Competition. Innovative Research in Life Sciences 2018. [DOI: 10.1002/9781119225898.ch22] [Reference Citation Analysis]
42 Majumder J, Chopra G. Stable and Reversible Functionalization of the Native Phosphate Groups on Live Cells.. [DOI: 10.1101/462044] [Reference Citation Analysis]
43 Knoepfler PS. Mapping and driving the stem cell ecosystem. Regenerative Medicine 2018;13:845-58. [DOI: 10.2217/rme-2018-0056] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
44 Lysaght T, Munsie M, Castricum A, Hui JH, Okada K, Sato Y, Sawa Y, Stewart C, Tan LK, Tan LH, Sugii S. A roundtable on responsible innovation with autologous stem cells in Australia, Japan and Singapore. Cytotherapy 2018;20:1103-9. [DOI: 10.1016/j.jcyt.2018.06.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
45 Touré SB, Kleiderman E, Knoppers BM. Bridging stem cell research and medicine: a learning health system. Regen Med 2018;13:741-52. [PMID: 30043682 DOI: 10.2217/rme-2017-0129] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
46 Ivanov AA, Danilova TI, Popova OP, Erohin AI, Semenihina ES. Peculiarities of Osteogenesis by Periosteal Cells after Experimental Ectopic Transplantation. Bull Exp Biol Med 2018;165:408-11. [PMID: 30003422 DOI: 10.1007/s10517-018-4181-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
47 Lotfipanah M, Azadeh F, Totonchi M, Omani-Samani R. Attitude of A Sample of Iranian Researchers toward The Future of Stem Cell Research. Cell J 2018;20:443-8. [PMID: 29845800 DOI: 10.22074/cellj.2018.5388] [Reference Citation Analysis]
48 Surani SH, Levine AD. State performance in pluripotent and adult stem cell research, 2009–2016. Regenerative Medicine 2018;13:309-20. [DOI: 10.2217/rme-2017-0125] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
49 Jevons LA, Houghton FD, Tare RS. Augmentation of musculoskeletal regeneration: role for pluripotent stem cells. Regen Med 2018;13:189-206. [PMID: 29557248 DOI: 10.2217/rme-2017-0113] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
50 Mester A, Opincariu D, Benedek I, Benedek I. Stem Cell Therapy in Wound Healing. Journal of Interdisciplinary Medicine 2017;2:20-4. [DOI: 10.1515/jim-2017-0094] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
51 Colao IL, Corteling R, Bracewell D, Wall I. Manufacturing Exosomes: A Promising Therapeutic Platform. Trends Mol Med. 2018;24:242-256. [PMID: 29449149 DOI: 10.1016/j.molmed.2018.01.006] [Cited by in Crossref: 185] [Cited by in F6Publishing: 201] [Article Influence: 46.3] [Reference Citation Analysis]
52 Sherley JL. Dose Determination for Stem Cell Medicine. Perinatal Stem Cells 2018. [DOI: 10.1016/b978-0-12-812015-6.00028-5] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
53 E. Ehanire T, Katz AJ. Challenges and Status of Adipose Cell Therapies: Translation and Commercialization. Cell Engineering and Regeneration 2018. [DOI: 10.1007/978-3-319-37076-7_56-1] [Reference Citation Analysis]
54 Vertès AA. Methods and practices to diversify cell-based products. Regen Med 2017;12:997-1013. [PMID: 29243940 DOI: 10.2217/rme-2017-0093] [Reference Citation Analysis]
55 . Introduction. Preservation of Cells 2017. [DOI: 10.1002/9781118989883.ch1] [Reference Citation Analysis]
56 Sipp D. Identity and ownership issues in the regulation of autologous cells. Regen Med 2017;12:827-38. [PMID: 29115180 DOI: 10.2217/rme-2017-0063] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
57 Lesage F, Zia S, Jiménez J, Deprest J, Toelen J. The amniotic fluid as a source of mesenchymal stem cells with lung-specific characteristics. Prenat Diagn 2017;37:1093-9. [PMID: 28842991 DOI: 10.1002/pd.5147] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
58 Zhang JY. Lost in translation? Accountability and governance of clinical stem cell research in China. Regen Med 2017;12:647-56. [PMID: 28976821 DOI: 10.2217/rme-2017-0035] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
59 Turner L. ClinicalTrials.gov, stem cells and ‘pay-to-participate’ clinical studies. Regenerative Medicine 2017;12:705-19. [DOI: 10.2217/rme-2017-0015] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
60 Bonter K, Breckenridge Z, Lachance S, Delisle J, Bubela T. Opportunities and challenges for the cellular immunotherapy sector: a global landscape of clinical trials. Regenerative Medicine 2017;12:623-36. [DOI: 10.2217/rme-2017-0031] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
61 Swioklo S, Ding P, Pacek AW, Connon CJ. Process parameters for the high-scale production of alginate-encapsulated stem cells for storage and distribution throughout the cell therapy supply chain. Process Biochemistry 2017;59:289-96. [DOI: 10.1016/j.procbio.2016.06.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 4.6] [Reference Citation Analysis]
62 Anasiz Y, Ozgul RK, Uckan-cetinkaya D. A New Chapter for Mesenchymal Stem Cells: Decellularized Extracellular Matrices. Stem Cell Rev and Rep 2017;13:587-97. [DOI: 10.1007/s12015-017-9757-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 2.6] [Reference Citation Analysis]
63 Pati S, Rasmussen TE. Cellular therapies in trauma and critical care medicine: Looking towards the future. PLoS Med 2017;14:e1002343. [PMID: 28700606 DOI: 10.1371/journal.pmed.1002343] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
64 El-serafi AT, El-serafi IT, Elmasry M, steinvall I, Sjöberg F. Skin regeneration in three dimensions, current status, challenges and opportunities. Differentiation 2017;96:26-9. [DOI: 10.1016/j.diff.2017.06.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
65 Kenney M, Patton D. Sub-national technology policy and commerce: evaluating the impacts of the California Institute for Regenerative Medicine. J Technol Transf 2018;43:47-68. [DOI: 10.1007/s10961-017-9580-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
66 Fung M, Yuan Y, Atkins H, Shi Q, Bubela T. Responsible Translation of Stem Cell Research: An Assessment of Clinical Trial Registration and Publications. Stem Cell Reports. 2017;8:1190-1201. [PMID: 28416287 DOI: 10.1016/j.stemcr.2017.03.013] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 10.0] [Reference Citation Analysis]
67 Lesage F, Jimenez J, Toelen J, Deprest J. Preclinical evaluation of cell-based strategies to prevent or treat bronchopulmonary dysplasia in animal models: a systematic review. J Matern Fetal Neonatal Med 2018;31:958-66. [PMID: 28277906 DOI: 10.1080/14767058.2017.1301927] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
68 Koliakos G. Stem Cells and Aging. Rejuvenation Research 2017;20:4-8. [DOI: 10.1089/rej.2016.1809] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
69 Shapiro G, Pelled G, Gazit D. Consideration of Biological Sex in Translating Regenerative Stem Cell Therapies. Principles of Gender-Specific Medicine 2017. [DOI: 10.1016/b978-0-12-803506-1.00019-x] [Reference Citation Analysis]
70 Rosemann A. Challenges to International Stem Cell Clinical Trials in Countries with Diverging Regulations. Stem Cells in Clinical Applications 2017. [DOI: 10.1007/978-3-319-59165-0_15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
71 Petersen A, Munsie M, Tanner C, Macgregor C, Brophy J. Stem Cell Tourism in Context. Stem Cell Tourism and the Political Economy of Hope 2017. [DOI: 10.1057/978-1-137-47043-0_1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
72 Swioklo S, Connon CJ. Short-term Storage of Cells for Application in Cell-based Therapies. Bioprocessing for Cell Based Therapies 2016. [DOI: 10.1002/9781118743362.ch7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
73 Whitaker M, Foley L, Ward S. Overview of the Cell Therapy Field. Bioprocessing for Cell Based Therapies 2016. [DOI: 10.1002/9781118743362.ch1] [Reference Citation Analysis]
74 Weinryb N, Bubela T. Stepping Into and Out of the Void: Funding Dynamics of Human Embryonic Stem Cell Research in California, Sweden, and South Korea. Stem Cell Rev Rep 2016;12:8-14. [PMID: 26432702 DOI: 10.1007/s12015-015-9626-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
75 Stacey GN, Hawkins JR. Cell Lines: Applications and Biosafety. Biological Safety 2016. [DOI: 10.1128/9781555819637.ch14] [Reference Citation Analysis]
76 Pati S, Pilia M, Grimsley JM, Karanikas AT, Oyeniyi B, Holcomb JB, Cap AP, Rasmussen TE. Cellular Therapies in Trauma and Critical Care Medicine: Forging New Frontiers. Shock 2015;44:505-23. [PMID: 26428845 DOI: 10.1097/SHK.0000000000000482] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 5.5] [Reference Citation Analysis]
77 Rosemann A, Bortz G, Vasen F, Sleeboom-faulkner M. Global regulatory developments for clinical stem cell research: diversification and challenges to collaborations. Regenerative Medicine 2016;11:647-57. [DOI: 10.2217/rme-2016-0072] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
78 Sorice S, Rustad KC, Li AY, Gurtner GC. The Role of Stem Cell Therapeutics in Wound Healing: Current Understanding and Future Directions. Plastic and Reconstructive Surgery 2016;138:31S-41S. [DOI: 10.1097/prs.0000000000002646] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
79 Codinach M, Blanco M, Ortega I, Lloret M, Reales L, Coca MI, Torrents S, Doral M, Oliver-Vila I, Requena-Montero M, Vives J, Garcia-López J. Design and validation of a consistent and reproducible manufacture process for the production of clinical-grade bone marrow-derived multipotent mesenchymal stromal cells. Cytotherapy 2016;18:1197-208. [PMID: 27424149 DOI: 10.1016/j.jcyt.2016.05.012] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 6.2] [Reference Citation Analysis]
80 Mount NM, Ward SJ, Kefalas P, Hyllner J. Cell-based therapy technology classifications and translational challenges. Philos Trans R Soc Lond B Biol Sci 2015;370:20150017. [PMID: 26416686 DOI: 10.1098/rstb.2015.0017] [Cited by in Crossref: 93] [Cited by in F6Publishing: 101] [Article Influence: 15.5] [Reference Citation Analysis]
81 Martino G. Bench-to-bedside translation of stem cell therapies: where are we now and where are we going? Regen Med 2016;11:347-9. [PMID: 27188381 DOI: 10.2217/rme-2016-0041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
82 Roura S, Pujal JM, Gálvez-Montón C, Bayes-Genis A. Quality and exploitation of umbilical cord blood for cell therapy: Are we beyond our capabilities? Dev Dyn 2016;245:710-7. [PMID: 27043849 DOI: 10.1002/dvdy.24408] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
83 Vertès AA. Deployment of stem cell technologies in industry and healthcare. Stem Cells in Regenerative Medicine 2016. [DOI: 10.1002/9781118846193.ch34] [Reference Citation Analysis]
84 Lazarus HM, Gerson SL. The History of Stem Cell Transplantation. Stem Cells in Regenerative Medicine 2016. [DOI: 10.1002/9781118846193.ch5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
85 Du L, Rachul C, Guo Z, Caulfield T. Gordie Howe's "Miraculous Treatment": Case Study of Twitter Users' Reactions to a Sport Celebrity's Stem Cell Treatment. JMIR Public Health Surveill 2016;2:e8. [PMID: 27227162 DOI: 10.2196/publichealth.5264] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
86 Subbot AM, Kasparova EA, Subbot AM, Kasparova EA. [Review of approaches to cell therapy in ophthalmology]. Vestn Oftalmol 2015;131:74-81. [PMID: 26845876 DOI: 10.17116/oftalma2015131574-81] [Reference Citation Analysis]
87 Swioklo S, Constantinescu A, Connon CJ. Alginate-Encapsulation for the Improved Hypothermic Preservation of Human Adipose-Derived Stem Cells. Stem Cells Transl Med. 2016;5:339-349. [PMID: 26826163 DOI: 10.5966/sctm.2015-0131] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 8.8] [Reference Citation Analysis]
88 Bisson I, Green E, Sharpe M, Herbert C, Hyllner J, Mount N. Landscape of current and emerging cell therapy clinical trials in the UK: current status, comparison to global trends and future perspectives. Regen Med 2015;10:169-79. [PMID: 25835481 DOI: 10.2217/rme.14.71] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
89 Benjaminy S, Lo C, Illes J. Social Responsibility in Stem Cell Research - Is the News All Bad? Stem Cell Rev and Rep 2016;12:269-75. [DOI: 10.1007/s12015-016-9646-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
90 Song YH, Shon SH, Shan M, Stroock AD, Fischbach C. Adipose-derived stem cells increase angiogenesis through matrix metalloproteinase-dependent collagen remodeling. Integr Biol (Camb) 2016;8:205-15. [PMID: 26758423 DOI: 10.1039/c5ib00277j] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 7.2] [Reference Citation Analysis]
91 Federico F, Spelat R. Dental Stem Cells in Regenerative Medicine: Clinical and Pre-clinical Attempts. Dental Stem Cells 2016. [DOI: 10.1007/978-3-319-28947-2_13] [Reference Citation Analysis]
92 Chancellor MB. Surgery for Underactive Bladder Treatment. The Underactive Bladder 2016. [DOI: 10.1007/978-3-319-23687-2_9] [Reference Citation Analysis]
93 Mahyudin F, Suroto H. Tissue Bank and Tissue Engineering. Advanced Structured Materials 2016. [DOI: 10.1007/978-3-319-14845-8_9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
94 Kamenova K, Caulfield T. Stem cell hype: media portrayal of therapy translation. Sci Transl Med 2015;7:278ps4. [PMID: 25761887 DOI: 10.1126/scitranslmed.3010496] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 8.1] [Reference Citation Analysis]
95 Schimke MM, Marozin S, Lepperdinger G. Patient-Specific Age: The Other Side of the Coin in Advanced Mesenchymal Stem Cell Therapy. Front Physiol 2015;6:362. [PMID: 26696897 DOI: 10.3389/fphys.2015.00362] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
96 Bubela T, McCabe C, Archibald P, Atkins H, Bradshaw SE, Kefalas P, Mujoomdar M, Packer C, Piret J, Raxworthy M, Soares M, Viswanathan S. Bringing regenerative medicines to the clinic: the future for regulation and reimbursement. Regen Med 2015;10:897-911. [PMID: 26565607 DOI: 10.2217/rme.15.51] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 5.3] [Reference Citation Analysis]
97 Matthews KR, Iltis AS. Unproven stem cell-based interventions and achieving a compromise policy among the multiple stakeholders. BMC Med Ethics 2015;16:75. [PMID: 26537611 DOI: 10.1186/s12910-015-0069-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
98 Niemansburg SL, Tempels TH, Dhert WJ, van Delden JJ, Bredenoord AL. Societal impacts of regenerative medicine: reflections on the views of orthopedic professionals. Regen Med 2015;10:17-24. [PMID: 25562349 DOI: 10.2217/rme.14.69] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
99 Heathman TR, Nienow AW, McCall MJ, Coopman K, Kara B, Hewitt CJ. The translation of cell-based therapies: clinical landscape and manufacturing challenges. Regen Med 2015;10:49-64. [PMID: 25562352 DOI: 10.2217/rme.14.73] [Cited by in Crossref: 207] [Cited by in F6Publishing: 214] [Article Influence: 29.6] [Reference Citation Analysis]
100 Hayakawa T, Aoi T, Bravery C, Hoogendoorn K, Knezevic I, Koga J, Maeda D, Matsuyama A, Mcblane J, Morio T, Petricciani J, Rao M, Ridgway A, Sato D, Sato Y, Stacey G, Sakamoto N, Trouvin J, Umezawa A, Yamato M, Yano K, Yokote H, Yoshimatsu K, Zorzi-morre P. Report of the international conference on regulatory endeavors towards the sound development of human cell therapy products. Biologicals 2015;43:283-97. [DOI: 10.1016/j.biologicals.2015.07.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
101 Dodson BP, Levine AD. Challenges in the translation and commercialization of cell therapies. BMC Biotechnol 2015;15:70. [PMID: 26250902 DOI: 10.1186/s12896-015-0190-4] [Cited by in Crossref: 65] [Cited by in F6Publishing: 72] [Article Influence: 9.3] [Reference Citation Analysis]
102 Dodson BP, Levine AD. Challenges in the translation and commercialization of cell therapies. BMC Biotechnol 2015;15:70. [PMID: 26250902 DOI: 10.1186/s12896-015-0190-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
103 Kellathur SN. Regulation of Cell- and Tissue-Based Therapeutic Products in Singapore. Tissue Eng Part A 2015;21:2802-5. [PMID: 26096855 DOI: 10.1089/ten.TEA.2014.0712] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
104 Lowenthal J, Sugarman J. Ethics and policy issues for stem cell research and pulmonary medicine. Chest 2015;147:824-34. [PMID: 25732448 DOI: 10.1378/chest.14-1696] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
105 Vertès AA. The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graft-versus-host disease. Chapter II: emerging transformational cytotherapies. Regenerative Medicine 2015;10:345-73. [DOI: 10.2217/rme.15.13] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
106 Rosemann A. Multi-country stem cell trials. Stem Cell Research 2015;14:396-400. [DOI: 10.1016/j.scr.2015.02.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
107 Malik NN, Durdy MB. Cell Therapy Landscape. Translational Regenerative Medicine. Elsevier; 2015. pp. 87-106. [DOI: 10.1016/b978-0-12-410396-2.00007-4] [Cited by in Crossref: 8] [Article Influence: 1.1] [Reference Citation Analysis]
108 Nasir A. Industry. Clinical Dermatology Trials 101 2015. [DOI: 10.1007/978-3-319-09027-6_13] [Reference Citation Analysis]
109 Petersen A, Tanner C, Munsie M. Between hope and evidence: how community advisors demarcate the boundary between legitimate and illegitimate stem cell treatments. Health (London) 2015;19:188-206. [PMID: 25367895 DOI: 10.1177/1363459314555240] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
110 Davies BM, Rikabi S, French A, Pinedo-Villanueva R, Morrey ME, Wartolowska K, Judge A, MacLaren RE, Mathur A, Williams DJ, Wall I, Birchall M, Reeve B, Atala A, Barker RW, Cui Z, Furniss D, Bure K, Snyder EY, Karp JM, Price A, Carr A, Brindley DA. Quantitative assessment of barriers to the clinical development and adoption of cellular therapies: A pilot study. J Tissue Eng 2014;5:2041731414551764. [PMID: 25383173 DOI: 10.1177/2041731414551764] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
111 Dekkers OM, Mummery CL, Rabelink TJ. A case for crowd sourcing in stem cell research. Stem Cells Transl Med 2014;3:1259-61. [PMID: 25232185 DOI: 10.5966/sctm.2014-0125] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
112 Mangir N, Akbal C, Tarcan T, Simsek F, Turkeri L. Mesenchymal stem cell therapy in treatment of erectile dysfunction: Autologous or allogeneic cell sources?: MSC in treatment of ED. Int J Urol 2014;21:1280-5. [DOI: 10.1111/iju.12585] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
113 Bubela T, McCabe C. Value-engineered translation for regenerative medicine: meeting the needs of health systems. Stem Cells Dev. 2013;22 Suppl 1:89-93. [PMID: 24304083 DOI: 10.1089/scd.2013.0398] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
114 Wang F, Chang G, Geng X. NGF and TERT co-transfected BMSCs improve the restoration of cognitive impairment in vascular dementia rats. PLoS One 2014;9:e98774. [PMID: 24887495 DOI: 10.1371/journal.pone.0098774] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
115 Main H, Munsie M, O'Connor MD. Managing the potential and pitfalls during clinical translation of emerging stem cell therapies. Clin Transl Med 2014;3:10. [PMID: 24949190 DOI: 10.1186/2001-1326-3-10] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
116 Atala A. Regenerative Bladder Augmentation Using Autologous Tissue—When Will We Get There? Journal of Urology 2014;191:1204-5. [DOI: 10.1016/j.juro.2014.02.086] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
117 Stacey GN, Day JG. Putting cells to sleep for future science. Nat Biotechnol 2014;32:320-2. [DOI: 10.1038/nbt.2869] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
118 Roura S, Pujal JM, Galvez-Monton C, Bayes-Genis A. The role and potential of umbilical cord blood in an era of new therapies: A review. Stem Cell Res Ther. 2015;6:123. [PMID: 26133757 DOI: 10.1186/s13287-015-0113-2] [Cited by in Crossref: 70] [Cited by in F6Publishing: 74] [Article Influence: 1.4] [Reference Citation Analysis]